CIDRAP newsletters options
Allergan, a pharmaceutical company based in Dublin, Ireland, yesterday announced that the US Food and Drug Administration (FDA) has approved an expanded indication for its antibiotic combination drug Avycaz (ceftazidime and avibactam) to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by gram-negative organisms.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The Global Polio Eradication Initiative (GPEI) has received early reports of two new wild poliovirus type 1 (WPV1) cases, both in Kandahar province, GPEI said in its weekly update today.
Protection against the H3N2 strain was 17%—and not statistically significant.
A new report from Brazil's Ministry of Health showed a steady rise in the number of yellow fever cases confirmed and suspected since an update posted last week. There are now 213 confirmed cases, 83 more than last week, and 1,080 suspected cases, an increase of 479 since the previous report.
A new story by the UK-based Bureau of Investigative Journalism alleges the last-resort antibiotic colistin is being widely used on Indian poultry farms, despite worldwide concerns that using the drug in food-producing animals could render it ineffective.
Recent gains in preventing the disease in pregnancy may be lost as resistance to prophylactic treatment rises.
Multiple factors may affect antibiotic overprescribing.
It's too soon to know if the study applies to people, but West Nile caused fetal brain damage and death in mice.
Brenda Fitzgerald, MD, director of the US Centers for Disease Control and Prevention (CDC), resigned today after a report that she bought tobacco stocks while leading the agency.
Anne Schuchat, MD, the CDC's principal deputy director who served as interim CDC director before Fitzgerald began her tenure last year, will resume that role, the Wall Street Journal and other news sources reported.
The Georgia Department of Public Health (GDPH) tuberculosis program is assisting with the investigation of two confirmed multidrug-resistant tuberculosis (MDR-TB) cases in the northeastern part of the state, according to Nancy Nydam, a communications official with the GDPH.
SEDRIC will bring together experts in infectious diseases, epidemiology, and human and animal health to identify gaps.
Routine testing as part of avian influenza surveillance in wild birds found low levels of H7 RNA in two mallards shot in December by hunters in Georgia's McIntosh Country.
Yesterday the Saudi Arabian Ministry of Health (MOH) reported a new case of MERS-CoV and announced the death of a previously reported MERS patient.
A 40-year-old Saudi woman from Riyadh is in stable condition after presenting with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus). The woman's source of infection is listed as "primary," meaning it's unlikely she contracted the disease from another person.
The rate of non-susceptible bloodstream infections was as high as 82% in some nations.
CutisPharma today announced that the US Food and Drug Administration (FDA) has approved Firvanq, the company's vancomycin oral solution for treating Clostridium difficile–associated diarrhea (CDAD) and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains.
The Saudi Arabian Ministry of Health (MOH) reported five new cases of MERS-CoV in updated reports released over the weekend.
The CDC notes 7 new kids' deaths and ILI levels nearing those seen in 2009.
Researchers conclude that neither technique used to ease antibiotic pressure is particularly effective.
New guidance today from the United Kingdom's National Institute for Health and Care Excellence (NICE) and Public Health England says general practitioners should not offer, and patients should not expect, antibiotics in most cases of acute sore throat.
